title: Are basal and glucagon-stimulated C-peptide values predictors of response to GLP-1 receptor agonists in type 2 diabetic patients?
authors.affiliation: Endocrinology and Metabolic Diseases Unit, Groupe Hospitalier Sud Reunion, Saint-Pierre, Reunion Island, France - jean-christophe.maiza@chu-reunion.fr.
authors.forename: Jean-Christophe
authors.initials: JC
authors.lastname: Maiza
authors.forename: Pierre
authors.initials: P
authors.lastname: Gérard
authors.forename: Olivier
authors.initials: O
authors.lastname: Rollot
authors.forename: Muriel
authors.initials: M
authors.lastname: Cogne
authors.forename: Eric
authors.initials: E
authors.lastname: Jarlet
authors.forename: Stephane
authors.initials: S
authors.lastname: Schneebeli
mesh_terms: D000328:Adult; D000368:Aged; D015415:Biomarkers / Q000097:blood; D002096:C-Peptide / Q000097:blood*; D003924:Diabetes Mellitus, Type 2 / Q000097:blood* / Q000188:drug therapy*; D005260:Female; D005934:Glucagon / Q000097:blood*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011237:Predictive Value of Tests; D000097789:Glucagon-Like Peptide-1 Receptor Agonists
chemical_list: D015415:Biomarkers; D002096:C-Peptide; D007004:Hypoglycemic Agents; D005934:Glucagon; D000097789:Glucagon-Like Peptide-1 Receptor Agonists